Exploiting a metabolic vulnerability in brain tumour stem cells using a brain-penetrant drug with safe profile
A. Burban, C. Tessier, M. Pinglaut…·A. Sharanek
This study shows that mubritinib targets brain tumour stem cells by inhibiting complex I of the electron transport chain, delays glioblastoma tumourigenesis, and is safe in mice.